Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SHE:002603)

China flag China · Delayed Price · Currency is CNY
16.16
-0.19 (-1.16%)
May 20, 2026, 11:25 AM CST
Market Cap27.32B +23.6%
Revenue (ttm)7.91B +24.6%
Net Income1.37B
EPS0.82
Shares Out1.67B
PE Ratio19.95
Forward PE18.17
Dividend1.00 (5.82%)
Ex-Dividend DateOct 22, 2025
Volume6,741,440
Average Volume17,478,856
Open16.42
Previous Close16.35
Day's Range16.12 - 16.42
52-Week Range13.78 - 21.58
Beta0.52
RSI40.39
Earnings DateApr 28, 2026

About SHE:002603

Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of medicine primarily in China. The company operates through Chemical and Biological Medicine, and Health Industry segments. It offers drugs for cardiac and premature ventricular beats, sinus bradycardia, chronic heart failure, integrated rhythm regulation, cold and respiratory, cardiovascular and cerebrovascular diseases, diabetes field, tumor medication, and others. The company sells its products through physical display and online. Shij... [Read more]

Sector Healthcare
Founded 1992
Employees 11,343
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002603
Full Company Profile

Financial Performance

Financial Statements